Pharmaceutical Executive April 23, 2024
LabConnect will utilize the consulting firm’s assets to improve its clinical trial services.
The mergers and acquisitions continue.
LabConnect announced that it has agreed to acquire A4P Consulting Ltd.1 The latter company is a scientific consultancy firm that focuses on the following areas: bioanalytical and biosample project management, biomarker strategy, and logistic solutions in support of both pre-clinical and clinical trials. LabConnect will bring A4P Consulting’s assets under its umbrella in an effort to provide better services related to pre-clinical and clinical trial goals.
In a press release, A4P co-founder and chief executive officer Ian James, Ph. D., said, “A4P was founded over 12 years ago by four individuals from the pharma industry with a vision of how Bioanalytical and...
Today's Sponsors
Today's Sponsor